MMS19 and head and neck squamous cell carcinoma: Strikingly, the authors found that amplification of MAGE-F1, a component of the E3 ubiquitin ligase complex that regulates MMS19 degradation, was associated with significant increases in total mutation burden in lung and head and neck squamous cell carcinomas.